References
- World Health Organization. Hepatitis B; July 2012; Available from: http://www.who.int/mediacentre/factsheets/fs204/en/
- Colvin HM, Mitchell AE. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; 2010.
- World Health Organization. vaccines and biological: WHO vaccine preventable disease monitoring system. Global summary 2009. Available at: www.who.int/immunization/documents/WHO_IVB_2009/en/index.html. Assessed October 23, 2012.
- Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 2004; 22:2791 - 9; http://dx.doi.org/10.1016/j.vaccine.2004.01.046; PMID: 15246613
- Fitzsimons D, François G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23:4158 - 66; http://dx.doi.org/10.1016/j.vaccine.2005.03.017; PMID: 15964484
- Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, et al. Hepatitis B variant in Europe. Lancet 1988; 2:1132 - 3; http://dx.doi.org/10.1016/S0140-6736(88)90541-7; PMID: 2460710
- Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother 2008; 61:766 - 8; http://dx.doi.org/10.1093/jac/dkn014; PMID: 18218641
- Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325 - 9; http://dx.doi.org/10.1016/0140-6736(90)91874-A; PMID: 1697396
- Hawkins AE, Gilson RJ, Gilbert N, Wreghitt TG, Gray JJ, Ahlers-de Boer I, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996; 24:8 - 14; http://dx.doi.org/10.1016/S0168-8278(96)80179-6; PMID: 8834018
- Zuckerman JN, Zuckerman AJ. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60:75 - 8; http://dx.doi.org/10.1016/j.antiviral.2003.08.013; PMID: 14638401
- Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994; 199:292 - 300; http://dx.doi.org/10.1006/viro.1994.1127; PMID: 8122362
- Fernholz D, Galle PR, Stemler M, Brunetto M, Bonino F, Will H. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 1993; 194:137 - 48; http://dx.doi.org/10.1006/viro.1993.1243; PMID: 8480417
- Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905 - 8; http://dx.doi.org/10.1086/323396; PMID: 11509998
- Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?. Bull World Health Organ 2010; 88:66 - 73; http://dx.doi.org/10.2471/BLT.08.065722; PMID: 20428355
- Gerlich WH, Bremer C, Saniewski M, Schüttler CG, Wend UC, Willems WR, et al. Occult hepatitis B virus infection: detection and significance. Dig Dis 2010; 28:116 - 25; http://dx.doi.org/10.1159/000282074; PMID: 20460899
- Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH, et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49:1621 - 9; http://dx.doi.org/10.1111/j.1537-2995.2009.02188.x; PMID: 19413737
- Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 2006; 12:198 - 203; http://dx.doi.org/10.3201/eid1203.050038; PMID: 16494742